DrugPatentWatch Database Preview
Details for Patent: 9,345,714
» See Plans and Pricing
Which drugs does patent 9,345,714 protect, and when does it expire?
Patent 9,345,714 protects CIPRODEX and is included in one NDA.
This patent has nineteen patent family members in sixteen countries.
Summary for Patent: 9,345,714
| Title: | Method of treating middle ear infections |
| Abstract: | Aqueous suspension formulations containing dexamethasone and ciprofloxacin are disclosed for the treatment of middle ear infections in human patients having an open tympanic membrane. |
| Inventor(s): | Wall; G. Michael (Fort Worth, TX), Conroy; Peter J. (Fort Worth, TX) |
| Assignee: | Alcon Pharmaceuticals Ltd. (Fribourg, CH) |
| Application Number: | 14/838,637 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,345,714 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 9,345,714
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | CIPRODEX | ciprofloxacin; dexamethasone | SUSPENSION/DROPS;OTIC | 021537-001 | Jul 18, 2003 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | TREATMENT OF ACUTE OTITIS MEDIA | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,345,714
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 313328 | Start Trial | |||
| Australia | 2002333671 | Start Trial | |||
| Brazil | 0212898 | Start Trial | |||
| Canada | 2459930 | Start Trial | |||
| China | 1231218 | Start Trial | |||
| China | 1555267 | Start Trial | |||
| Germany | 60208216 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
